74 related articles for article (PubMed ID: 26028975)
21. VEGF targets the tumour cell.
Goel HL; Mercurio AM
Nat Rev Cancer; 2013 Dec; 13(12):871-82. PubMed ID: 24263190
[TBL] [Abstract][Full Text] [Related]
22. The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.
Lawicki S; Będkowska GE; Gacuta-Szumarska E; Szmitkowski M
J Ovarian Res; 2013 Jul; 6(1):45. PubMed ID: 23819707
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer.
Wu J; Liu X; Wang Y
BMC Clin Pathol; 2013 May; 13():15. PubMed ID: 23697837
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of VEGF and VEGF-C in patients with endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kulikowski M; Niklinski J
Eur Cytokine Netw; 2011 Mar; 22(1):45-51. PubMed ID: 21411409
[TBL] [Abstract][Full Text] [Related]
26. Global cancer statistics.
Jemal A; Bray F; Center MM; Ferlay J; Ward E; Forman D
CA Cancer J Clin; 2011; 61(2):69-90. PubMed ID: 21296855
[TBL] [Abstract][Full Text] [Related]
27. The genesis and evolution of high-grade serous ovarian cancer.
Bowtell DD
Nat Rev Cancer; 2010 Nov; 10(11):803-8. PubMed ID: 20944665
[TBL] [Abstract][Full Text] [Related]
28. Serum sFas, leptin, and VEGF in patients with ovarian cancer and benign tumors.
Vysotskii MM; Digaeva MA; Kushlinskii NE; Abbasova SG; Laktionov KP; Ermilova VD; Bakhoeva KA; Kryuk YV; Manukhin IB
Bull Exp Biol Med; 2009 Nov; 148(5):810-4. PubMed ID: 20396799
[TBL] [Abstract][Full Text] [Related]
29. The biology of ovarian cancer: new opportunities for translation.
Bast RC; Hennessy B; Mills GB
Nat Rev Cancer; 2009 Jun; 9(6):415-28. PubMed ID: 19461667
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
31. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.
Gorelik E; Landsittel DP; Marrangoni AM; Modugno F; Velikokhatnaya L; Winans MT; Bigbee WL; Herberman RB; Lokshin AE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):981-7. PubMed ID: 15824174
[TBL] [Abstract][Full Text] [Related]
32. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.
Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ
Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
Harlozinska A; Sedlaczek P; Kulpa J; Grybos M; Wójcik E; Van Dalen A; Einarsson R
Anticancer Res; 2004; 24(2C):1149-57. PubMed ID: 15154640
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic odds ratio: a single indicator of test performance.
Glas AS; Lijmer JG; Prins MH; Bonsel GJ; Bossuyt PM
J Clin Epidemiol; 2003 Nov; 56(11):1129-35. PubMed ID: 14615004
[TBL] [Abstract][Full Text] [Related]
35. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.
Whiting P; Rutjes AW; Reitsma JB; Bossuyt PM; Kleijnen J
BMC Med Res Methodol; 2003 Nov; 3():25. PubMed ID: 14606960
[TBL] [Abstract][Full Text] [Related]
36. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
[TBL] [Abstract][Full Text] [Related]
37. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
[TBL] [Abstract][Full Text] [Related]
38. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.
Walter SD
Stat Med; 2002 May; 21(9):1237-56. PubMed ID: 12111876
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of serum VEGF in women with ovarian tumors.
Oehler MK; Caffier H
Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
[TBL] [Abstract][Full Text] [Related]
40. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
Obermair A; Tempfer C; Hefler L; Preyer O; Kaider A; Zeillinger R; Leodolter S; Kainz C
Br J Cancer; 1998 Jun; 77(11):1870-4. PubMed ID: 9667661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
